U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948487) titled 'Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis' on April 15.
Brief Summary: This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
Study Start Date: June 04
Study Type: OBSERVATIONAL
Condition:
Gastritis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewoong Pharmaceutical Co. LTD.
Disclaimer: Curated by HT Syndication....